COVID-19 and immunosuppressive treatment in Multiple Sclerosis - what have we learned?

MS (multiple sclerosis) is an autoimmune disease that affects young adults and causes damage to the central nervous system. Around 13,000 people live with the disease in Norway today. There is no curative treatment, but immunosuppressive drugs have in recent decades given a far better prognosis than before, and made it possible to live with the disease with less loss of function. During the Covid-19 pandemic, the question arose: Are patients on immunosuppressive treatment at greater risk of serious infection than others? And does vaccination work optimally? Medical doctor and research fellow Hilde Marie Torgauten (Haukeland University Hospital) has investigated just this and will tell you about the preliminary results from her research. The talk will be held in Norwegian.

The event will last about 45 minutes. Coffee/tea and biscuits will be served (please bring your own cup!). Everyone is welcome!